Back to Search

PRASANNA MARATHE, MD

MD

Diagnostic Radiology Physician

NPI: 1588169197IndividualAccepts Medicare

Specialties, Licenses & Credentials

Diagnostic Radiology PhysicianPrimary

Radiology — Diagnostic Radiology

Code: 2085R0202X

D96562(MD)

CMS Specialties

PrimaryDIAGNOSTIC RADIOLOGY

Education

MEDICAL COLLEGE OF WISCONSIN

Class of 2018

Research & Publications (20)

Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate.
PMID 19396600·Cancer Chemother Pharmacol·2009
7-preclinical
Novel tricyclic inhibitors of IkappaB kinase.
PMID 19267461·J Med Chem·2009
7-preclinical
Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
PMID 17429625·Cancer Chemother Pharmacol·2008
4-observational
Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor.
PMID 18395443·Bioorg Med Chem Lett·2008
7-preclinical
The discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994)-A potent and efficacious p38alpha MAP kinase inhibitor.
PMID 18313298·Bioorg Med Chem Lett·2008
7-preclinical
Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activities.
PMID 18690676·J Med Chem·2008
7-preclinical
A liquid chromatography tandem mass spectrometry method for the quantification of indocyanine green in dog plasma and bile.
PMID 18295429·J Pharm Biomed Anal·2008
4-observational
Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215).
PMID 18288793·J Med Chem·2008
7-preclinical
Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors.
PMID 18072718·J Med Chem·2008
7-preclinical
Projection of exposure and efficacious dose prior to first-in-human studies: how successful have we been?
PMID 17899327·Pharm Res·2008
7-preclinical
Benzothiazole based inhibitors of p38alpha MAP kinase.
PMID 18296051·Bioorg Med Chem Lett·2008
7-preclinical
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors.
PMID 18479916·Bioorg Med Chem Lett·2008
7-preclinical
Development and validation of a preclinical food effect model.
PMID 17075867·J Pharm Sci·2007
7-preclinical
Development of an in vivo rat screen model to predict pharmacokinetic interactions of CYP3A4 substrates.
PMID 17896322·Xenobiotica·2007
7-preclinical
Effect of commonly used organic solvents on the kinetics of cytochrome P450 2B6- and 2C8-dependent activity in human liver microsomes.
PMID 17709370·Drug Metab Dispos·2007
8-other
5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.
PMID 17606372·Bioorg Med Chem Lett·2007
7-preclinical
Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.
PMID 17368025·Bioorg Med Chem Lett·2007
7-preclinical
New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.
PMID 17270437·Bioorg Med Chem Lett·2007
7-preclinical
In vivo animal models for investigating potential CYP3A- and Pgp-mediated drug-drug interactions.
PMID 17073574·Curr Drug Metab·2006
6-review
Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor.
PMID 16570908·J Med Chem·2006
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
600 N WOLFE ST
BALTIMORE, MD 21287

Locations (2)

Practice Location

600 N WOLFE ST, BALTIMORE, MD
(410) 955-5000

Practice Location

800 ROSE ST # C-246, LEXINGTON, KY
(859) 323-6162

Quick Facts

NPI
1588169197
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
2
Years in Practice
8
Publications
20

Are you this provider?

Claim Your Profile